The Effect of Tobacco Blend Additives on the Retention of Nicotine and Solanesol in the Human Respiratory Tract and on Subsequent Plasma Nicotine Concentrations during Cigarette Smoking

Chemical Research in Toxicology

Volumn 17, Issue 4, 2004, Pages 537-544

  Armitage, Alan K ^a   Dixon, Michael ^b   Frost, Barrie E ^c   Mariner, Derek C ^b,c   Sinclair, Neil M ^c  

^a Sycamore Lodge   (United Kingdom)

^b BRITISH AMERICAN TOBACCO   (United Kingdom)

^c Rothmans International   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM DERIVATIVE; CIGARETTE SMOKE CONDENSATE; DIAMMONIUM PHOSPHATE; NICOTINE; SOLANESOL; UNCLASSIFIED DRUG; UREA;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; INHALATION; MALE; MOUTH; RESPIRATORY SYSTEM; TOBACCO; VENOUS BLOOD;

ADMINISTRATION, INHALATION; ADULT; GANGLIONIC STIMULANTS; HUMANS; MALE; MOUTH; NICOTINE; RESPIRATION; RESPIRATORY SYSTEM; SMOKING; TERPENES; TISSUE DISTRIBUTION; TOBACCO;

NICOTIANA TABACUM;

EID: 1942518314     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0340753     Document Type: Article

References (39)

1. Leffingwell, J. C. (1999) Basic chemical constituents of tobacco leaf and differences among types. In Tobacco: Production, Chemistry and Technology (Davis, D. L., and Nielsen, M. T., Eds.) pp 265-284, Blackwell Science Ltd., Oxford.
2. Dixon, M., Lambing, K., and Seeman, J. I. (2000) On the transfer of nicotine from tobacco to the smoker. A brief review of ammonia and "pH" factors. Beitrage Tabaksforschung 19 (2), 103-113.
3. Pankow, J. F., Mader, B. T., Isabelle, L. M., Luo, W., Pavlick, A., and Liang, C. (1997) Conversion of nicotine in tobacco smoke to its volatile and free-base form through the action of gaseous ammonia. Environ. Sci. Technol. 31, 2428-2433.
4. Hurt, R. D., and Robinson, C. R. (1998) Prying open the door to the tobacco industry's secrets about nicotine. J. Am. Med. Assoc. 280, 1173-1181.
5. Bates, C., McNeill, A., Jarvis, M., and Gray, N. (1999) The future of tobacco product regulation and labeling in Europe: implications for the forthcoming European Union directive. Tobacco Control 8, 225-235.
6. Stirling, E. M., Collett, C. W., and Ropss, J. A. (1996) Assessment of nonsmokers exposure to environmental tobacco smoke using personal-exposure and fixed location monitoring. Indoor Built Environ. 5, 112-125.
7. International Standards Organization (1991) ISO 4387: Methods for Chemical Analysis of Tobacco and Tobacco Products. Determination of Total and Nicotine-Free Dry Particulate Matter Using a Routine Analytical Smoking Machine, ISO.
8. International Standards Organization (1991) ISO 10315: Methods for Chemical Analysis of Tobacco and Tobacco Products. Determination of Nicotine in Smoke Condensate of Cigarettes (Gas-Chromatographic Method).
9. International Standards Organization (1995) ISO 8454: Methods for Chemical Analysis of Tobacco and Tobacco Smoke Products. Determination of Carbon Monoxide in the Vapour Phase of Cigarette Smoke (NDIR Method).
10. Creighton, D. E., Noble, M. J., and Whewell, R. T. (1978) Instruments to measure, record and duplicate human smoking patterns. In Smoking Behaviour (Thornton, R. E., Ed.) pp 277-288, Churchill Livingstone, Edinburgh, London and New York.
11. U.S. Department of Health and Human Services (USDHHS) (1988) The Health Consequences of Smoking: Nicotine Addiction, Public Health Services, Washington, DC.
12. Guyatt, A. R., Holmes, M. A., and Cumming, G. (1981) Can carbon monoxide be absorbed from the upper respiratory tract in man? Eur. J. Respir. Dis. 62, 383-390.
13. Creighton, D. E., and Lewis, P. H. (1978) The effect of smoking pattern on smoke deliveries. In Smoking Behaviour (Thornton, R. E., Ed.) pp 289-314, Churchill Livingstone, Edinburgh, London and New York.
14. American Society for Testing and Materials, D6271-98 (1998) Standard Test Method for Estimating Contribution of Environmental Tobacco Smoke to Respirable Suspended Particles Based on Solanesol.
15. American Society for Testing and Materials D5075-96e1 (1996) Standard Test Method for Nicotine and 3-Ethenylpyridine in Indoor Air.
16. Nehls, G. J., and Ackland, G. G. (1973) Procedures for handling aerometric data. J. Air Pollut. Assoc. 23, 180-184.
17. Pankow, J. F. (2001) A consideration of the role of gas/particle partitioning in the deposition of nicotine and other tobacco smoke compounds in the respiratory tract. Chem. Res. Toxicol. 14 (11), 1465-1481.
18. Pankow, J. F., Tavakoli, A. D., Luo, W., and Isabelle, L. M (2003) Percent free base nicotine in the tobacco smoke particulate matter of selected commercial and reference cigarettes. Chem. Res. Toxicol. 16 (8), 1014-1018.
19. Frost, B. E., Mariner, D. C., and Sinclair, N. M. (1998) Factors relating to nicotine physio-chemistry and retention in human smokers. Proceedings of the CORESTA Congress, October 1998, Brighton, U.K., pp 211-218.
20. Lewis, D. A., Colbeck, I., and Mariner, D. C. (1994) Dilution of mainstream tobacco smoke and its effects upon the evaporation and diffusion of nicotine. J. Aerosol Sci. 26, 841-846.
21. Morie, G. P. (1972) Fraction of protonated and unprotonated nicotine in tobacco smoke at various pH values. Tob. Sci. 16, 167.
22. Rodgman, A. (2000) Smoke pH: A review. Beitrage Tabaksforschung 19, 117-139.
23. Ellis, C. L., Cox, R. H., Callicutt, C. H., Laffoon, S. W., Podraza, K. F., Seeman, J. I., Kinser, R. D., Farthing, D. E., and Hsu, F. H. (1999) The effect of ingredients added to tobacco in a commercial Marlboro Lights cigarette on FTC nicotine yield, "smoke pH" and Cambridge filter trapping effiency. Proceedings of the CORESTA Smoke and Technology meeting, Innsbruck, Austria, September 5-8. CORESTA Bull. 3, 108.
24. U.S. Food and Drug Administration (1995) Notice in Federal Register, August 11. Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco Products to Protect Children and Adolescents: Proposed Rule and Analysis Regarding FDA's Jurisdiction over Nicotine Containing Cigarettes and Smokeless Tobacco Products, U.S. Food and Drug Administration, Washington, DC.
25. Dr. Kelley St. Charles, personal communication.
26. Mariner, D. C., and Frost, B. E. (1998) Determination of nicotine evaporation from mainstream smoke using denuder tubes. In CORESTA Proceedings, pp 206-210, Brighton, England, 11-15 October 1998.
27. Cochran, E. W., Joseph, M. J., Stinson, S. L., and Summers, S. S. (2003) Application of a diffusion-denuder method for the investihgation of the effects of 'smoke pH' on vapour phase nicotine yields from different types of cigarettes. Beitrage Tabaksforschung 20 (6), 365-372.
28. Gori, G. B., Benowitz, N. L., and Lynch, C. J. (1986) Mouth versus deep airway absorption of nicotine in cigarette smokers. Pharmacol. Biochem. Behav. 25, 1181-1186.
29. Zacny, J. P., Stitzer, M. L., Brown, F. J., Yingling, J. E., and Griffiths, R. R. (1987) Human cigarette smoking: effects of puff and inhalation parameters on smoke exposure. J. Pharm. Exp. Ther. 240, 554-564.
30. Lunell, E., Bergstrom, M., Antoni, G., Langstrom, B., and Nordberg, A. (1996) Nicotine deposition and body distribution from a nicotine inhaler and a cigarette studied with positron emission tomography. Clin. Pharmacol. Ther. 59, 593-594.
31. Bergstrom, M., Nordberg, A., Lunell, E., Antoni, G., and Langstrom, B. (1995) Regional deposition of inhaled 11C-nicotine vapor in the human airway as visualized by positron emission tomography. Clin. Pharmacol. Ther. 57, 309-317.
32. Russell, M. A. H., Jarvis, M. J., Sutherland, G., and Feyerabend, C. (1987) Nicotine replacement in smoking cessation. Absorption of nicotine vapor from smoke-free cigarettes. J. Am. Med. Assoc. 257, 3262-3265.
33. Schuh, K. J., Schuh, L. M., Henningfield, J. E., and Stitzer, M. L. (1997) Nicotine nasal spray and vapor inhaler: abuse liability assessment Pyschopharmacology 130, 352-361.
34. Molander, L., Lunell, E., Anderson, S.-B., and Kuylenstierna, F. (1996) Dose released and absolute bioavailability of nicotine from a nicotine vapour inhaler Clin. Pharmacol. Ther. 59, 394-400.
35. Russell, M. A. H., and Feyerabend, C. (1978) Cigarette smoking: a dependence on high-nicotine boli. Drug Metab. Rev. 8, 29-57.
36. Royal College of Physicians of London (2000) Nicotine Addiction in Britain: A Report of the Tobacco Advisory Group of the Royal College of Physicians, pp 36-37
37. Rose, J. E., Behm, F. M., Westman, E. C., and Coleman, R. E. (1999) Arterial nicotine kinetics during cigarette smoking and intravenous nicotine administration: implications for addiction. Drug Alcohol Depend. 56, 99-107.
38. Henningfield, J. E., and Fant, R. V. (2000) Nicotine delivery systems: Implications for abuse potential, medications development, and public health. In Nicotine and Public Health (Ferrence, R., Slade, J., Room, R., and Pope, M., Eds.) pp 229-247, American Public Health Association, Washington, DC.
39. Benowitz, N. L. (1996) Report of Canada's Expert Committee on Cigarette Modifications-Conference Proceedings March 1996, pp 54, 80.